Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
“Dengue virus 1 structural proteins” is a collective term referring to the three main structural proteins found in all dengue viruses, including type 1 (DENV1): the **capsid (C)**, **pre-membrane/membrane (prM/M)**, and **envelope (E)** proteins[4][3]. These proteins form the viral particle: the capsid protein encapsidates the viral RNA and interacts with the lipid membrane; the prM/M protein organizes the outer structure and aids in particle maturation; and the E protein mediates viral attachment, membrane fusion, and is the main antigenic determinant for neutralizing antibodies[4][3][1]. These structural proteins are key in the viral life cycle and represent major therapeutic and vaccine targets[3][4]. Drugs inhibiting their function have shown antiviral effects in laboratory experiments. However, “Dengue virus 1 structural proteins” is a grouping, not a single molecule or unified target, so is_incorrect should be set to true for target standardization purposes (preferred canonical forms should be for individual proteins such as “Dengue virus envelope protein,” “Dengue virus capsid protein,” etc.)[3]. If you require structured data for each individual protein (capsid, prM/M, or E), it is best to query those specifically.
Inhibition of capsid protein dimerization (ST-148) - Inhibition of envelope protein-mediated membrane fusion (various small molecules, including 3-110-22 and others)[3]
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dengue virus 1 structural protein.